newwin
Luciann Nguyen
Settings
← Accounts
academic

University of California, Irvine

48
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

University of California, Irvine

New trial — Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

New trialNCT07064018
48/100
Opportunity
Commercial fit6/25
Clinical timing20/20
Biomarker need5/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5

New phase 1_2 trial NCT07064018 posted by University of California, Irvine: "Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies". New trial on a phase 1_2 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 53 days ago.

ConfidenceHigh · 87%clinical development · translational medicine · clinical operations
Draft outreachReview

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

TrialPhaseTesting language
NCT07064018
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
phase 1 2
mol. elig.